Page last updated: 2024-10-15
gdp-4-keto-6-deoxymannose
Description
GDP-4-dehydro-6-deoxy-alpha-D-mannose : A GDP-sugar having 4-dehydro-6-deoxy-alpha-D-mannose as the sugar portion. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 135398621 |
CHEBI ID | 16955 |
SCHEMBL ID | 151947 |
MeSH ID | M0154280 |
Synonyms (26)
Synonym |
---|
guanosine 5'-(trihydrogen diphosphate), p'-(6-deoxy-alpha-d-lyxo-hexopyranos-4-ulos-1-yl) ester |
18186-48-6 |
CHEBI:16955 |
guanosine 5'-[3-(6-deoxy-alpha-d-lyxo-hexopyranosyl-4-ulose) dihydrogen diphosphate] |
guanosine diphosphate-4-keto-6-deoxy-d-mannose |
gdp-4-dehydro-d-rhamnose |
gdp-4-dehydro-6-deoxy-alpha-d-mannose |
gdp-4-keto-6-deoxymannose |
C01222 , |
GDP-4-DEHYDRO-6-DEOXY-D-MANNOSE , |
gdp-4-dehydro-6-deoxy-d-talose |
gdp-4-oxo-6-deoxy-d-mannose |
gdp-4-keto-6-deoxy-d-mannose |
[[(2r,3s,4r,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3s,4r,6r)-3,4-dihydroxy-6-methyl-5-oxooxan-2-yl] hydrogen phosphate |
SCHEMBL151947 |
{[(2r,3s,4r,5r)-5-(2-amino-6-oxo-6,9-dihydro-1h-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[(2r,3s,4r,6r)-3,4-dihydroxy-6-methyl-5-oxooxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]phosphinic acid |
gdp-4-keto-6-d-deoxymannose |
gdp-4-oxo-6-deoxymannose |
gdp-4-keto-6deoxymannose |
PNHLMHWWFOPQLK-BKUUWRAGSA-N |
Q27102151 |
[[(2~{r},3~{s},4~{r},5~{r})-5-(2-azanyl-6-oxidanylidene-1~{h}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{r},3~{s},4~{r},6~{r})-6-methyl-3,4-bis(oxidanyl)-5-oxidanylidene-oxan-2-yl] hydrogen phosphate |
f7e , |
[[(2r,3s,4r,5r)-5-(2-amino-6-oxo-1h-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3s,4r,6r)-3,4-dihydroxy-6-methyl-5-oxooxan-2-yl] hydrogen phosphate |
[(2s,3s,4r,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-[[(2r,3r,4s,6s)-3,4 |
DTXSID60864645 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Roles (2)
Role | Description |
---|---|
Escherichia coli metabolite | Any bacterial metabolite produced during a metabolic reaction in Escherichia coli. |
mouse metabolite | Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
Class | Description |
---|---|
GDP-sugar | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Pathways (13)
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |